CLIA Waiver Guidance To Address Quality Control Requirements - FDA

FDA plans to release an interim guidance detailing the specifics of Clinical Laboratory Improvement Amendments (CLIA) waiver requirements as soon as early November, according to agency officials.

More from Archive

More from Medtech Insight